SECOND SUPPLEMENTAL INDENTURE dated as of February 28, 2014 among PDL BIOPHARMA, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as TrusteeSecond Supplemental Indenture • March 3rd, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 3rd, 2014 Company Industry JurisdictionSECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of February 28, 2014, between PDL BioPharma, Inc., a Delaware corporation (the “Company”) and The Bank of New York Mellon Trust Company, N.A., a national banking association, as Trustee (the “Trustee”).
ROYALTY PURCHASE AND SALE AGREEMENT dated as of October 18, 2013 between DEPOMED, INC., DEPO DR SUB, LLC, as Seller, and PDL BIOPHARMA, INC., as PurchaserRoyalty Purchase and Sale Agreement • March 3rd, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 3rd, 2014 Company Industry JurisdictionThis ROYALTY PURCHASE AND SALE AGREEMENT (this “Royalty Purchase and Sale Agreement”) dated as of October 18, 2013 is among Depomed, Inc., a California corporation (“Depomed”), Depo DR Sub, LLC, a Delaware limited liability company (the “Seller,” and together with Depomed, the “Selling Parties”) and PDL BioPharma, Inc., a Delaware corporation (the “Purchaser”).